Beacon Financial Strategies CORP
Source: SEC Form 13F · as of Mar 2026Beacon Financial Strategies CORP holds 18 biotech & pharma companies tracked by BioSniper, totaling $2.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$2.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 801 | $737K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 11,358 | $627K |
| MRKMerck & Co., Inc. | 3,794 | $456K |
| JNJJOHNSON & JOHNSON | 1,655 | $404K |
| PFEPFIZER INC | 7,714 | $217K |
| ABBVAbbVie Inc. | 791 | $172K |
| NVSNovartis AG | 489 | $75K |
| ABTABBOTT LABORATORIES | 685 | $70K |
| BMYBRISTOL MYERS SQUIBB CO | 708 | $43K |
| ELVElevance Health Inc. | 130 | $38K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 80 | $22K |
| PMPhilip Morris International Inc | 119 | $20K |
| VTRSViatris Inc | 1,052 | $14K |
| ZBHZimmer Biomet Holdings Inc. | 24 | $2K |
| OGNOrganon & Co. | 283 | $2K |
| DTILPRECISION BIOSCIENCES INC | 172 | $946 |
| CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 4 | $690 |
| HUMAHumacyte Inc. | 850 | $516 |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.